NCT01190202View on ClinicalTrials.gov

Epidemiology Study of Malaria Transmission Intensity in Africa

NACompletedINTERVENTIONAL
Enrollment

21,618

Participants

Timeline

Start Date

March 14, 2011

Primary Completion Date

December 20, 2013

Study Completion Date

December 20, 2013

Conditions
MalariaMalaria Vaccines
Interventions
PROCEDURE

Blood sampling

Capillary blood samples collected by finger/heel prick

PROCEDURE

Assessment of body temperature

Assessment of axial body temperature with a digital thermometer

Trial Locations (8)

Unknown

GSK Investigational Site, Ouagadougou

GSK Investigational Site, Lambaréné

GSK Investigational Site, Kintampo

GSK Investigational Site, Kumasi

GSK Investigational Site, Kisumu

GSK Investigational Site, Lilongwe

GSK Investigational Site, Dar es Salaam

GSK Investigational Site, Korogwe, Tanga

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

The PATH Malaria Vaccine Initiative (MVI)

OTHER

lead

GlaxoSmithKline

INDUSTRY

NCT01190202 - Epidemiology Study of Malaria Transmission Intensity in Africa | Biotech Hunter | Biotech Hunter